Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.
Peptide Synthesis IndustryThe global peptide synthesis market is poised for significant growth, with its valuation projected to increase from USD 520.0 million in 2023 to an impressive USD 1.1 billion ...
As global markets navigate a period of mixed performance, with major indices like the S&P 500 and Nasdaq Composite wrapping up another strong year despite recent fluctuations, investors are keenly ...
With rising investments in infrastructure, research, and development, coupled with the expansion of international trade and emerging markets, companies in the Bioactive Proteins and Peptides sector ...